Vident Investment Advisory’s Boston Scientific BSX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,719	Closed	-$633K	–	156
2023 Q2	$633K	Sell	11,719 -3,897	-25%	-$204K	0.02%	605
2023 Q1	$781K	Buy	15,616 +1,043	+7%	+$49.2K	0.03%	607
2022 Q4	$674K	Buy	14,573 +1,689	+13%	+$73.1K	0.03%	608
2022 Q3	$390K	Buy	12,884 +1,441	+13%	+$57.8K	0.01%	837
2022 Q2	$425K	Sell	11,443 -6,640	-37%	-$270K	0.01%	910
2022 Q1	$799K	Sell	18,083 -1,233	-6%	-$53.4K	0.02%	781
2021 Q4	$821K	Sell	19,316 -16,132	-46%	-$678K	0.02%	778
2021 Q3	$1.54M	Buy	35,448 +22,658	+177%	+$1M	0.05%	543
2021 Q2	$547K	Sell	12,790 -12,180	-49%	-$512K	0.02%	812
2021 Q1	$965K	Buy	24,970 +5,711	+30%	+$216K	0.03%	621
2020 Q4	$692K	Buy	19,259 +686	+4%	+$24.7K	0.03%	633
2020 Q3	$710K	Buy	18,573 +7,733	+71%	+$298K	0.04%	586
2020 Q2	$381K	Buy	+10,840	New	+$390K	0.02%	716
2018 Q1	–	Sell	-20,007	Closed	-$496K	–	900
2017 Q4	$496K	Buy	+20,007	New	+$552K	0.02%	578
2016 Q4	–	Sell	-20,070	Closed	-$478K	–	381
2016 Q3	$478K	Buy	+20,070	New	+$479K	0.06%	363
2015 Q4	–	Sell	-218	Closed	-$4K	–	435
2015 Q3	$4K	Sell	218 -1,568	-88%	-$26.8K	﹤0.01%	885
2015 Q2	$32K	Buy	+1,786	New	+$31.9K	﹤0.01%	826